NEVRO CORP
DelistedCIK 1444380fmd_01CM0EEJTTP6MD4GM9AV11XJ8JManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2012 to Dec 31, 2024, 49 periods
Latest annual · FY2024
Millions- Total revenues
- 409
- Gross profit
- 270
- Operating income
- (126)
- Net income
- (113)
- Free cash flow
- (29)
Latest quarter · Q4 FY2024
Millions- Total revenues
- 106
- Gross profit
- 66
- Operating income
- (51)
- Net income
- (53)
- Free cash flow
- 17
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2021 to FY2024
- +1.8%
- Revenue, 5 yearsFY2019 to FY2024
- +0.9%
- Net income, 5 yearsFY2019 to FY2024
- n/m
NEVRO CORP financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Revenue | $408.5 million | $425.2 million | -3.9% | 10-K 2025-03-04 · proof |
| Gross profit | $269.5 million | $290.1 million | -7.1% | 10-K 2025-03-04 · proof |
| Operating income | -$126.2 million | -$99.3 million | 10-K 2025-03-04 · proof | |
| Net income | -$113.4 million | -$92.2 million | 10-K 2025-03-04 · proof | |
| Cash from operating activities | -$19.4 million | -$58.8 million | 10-K 2025-03-04 · proof | |
| Free cash flow | -$29.2 million | -$67.4 million | 10-K 2025-03-04 · proof | |
| Total assets | $553.8 million | $635.7 million | -12.9% | 10-K 2025-03-04 · proof |
| Total liabilities | $322.8 million | $342.6 million | -5.8% | 10-K 2025-03-04 · proof |
| Cash and cash equivalents | $94.5 million | $104.2 million | -9.3% | 10-K 2025-03-04 · proof |
| Total debt | $225.6 million | $211.5 million | +6.7% | 10-K 2025-03-04 · proof |
- What was NEVRO CORP's revenue in fiscal 2024?
- NEVRO CORP reported revenue of $408.5 million for fiscal 2024 (the year ended Dec 31, 2024), against $425.2 million the year before (-3.9%). Source: the 10-K filed with the SEC on Mar 4, 2025. SEC
- What was NEVRO CORP's gross profit in fiscal 2024?
- NEVRO CORP reported gross profit of $269.5 million for fiscal 2024 (the year ended Dec 31, 2024), against $290.1 million the year before (-7.1%). Source: the 10-K filed with the SEC on Mar 4, 2025. SEC
- What was NEVRO CORP's operating income in fiscal 2024?
- NEVRO CORP reported operating income of -$126.2 million for fiscal 2024 (the year ended Dec 31, 2024), against -$99.3 million the year before. Source: the 10-K filed with the SEC on Mar 4, 2025. SEC
- What was NEVRO CORP's net income in fiscal 2024?
- NEVRO CORP reported net income of -$113.4 million for fiscal 2024 (the year ended Dec 31, 2024), against -$92.2 million the year before. Source: the 10-K filed with the SEC on Mar 4, 2025. SEC
- What was NEVRO CORP's cash from operating activities in fiscal 2024?
- NEVRO CORP reported cash from operating activities of -$19.4 million for fiscal 2024 (the year ended Dec 31, 2024), against -$58.8 million the year before. Source: the 10-K filed with the SEC on Mar 4, 2025. SEC
- What was NEVRO CORP's free cash flow in fiscal 2024?
- NEVRO CORP reported free cash flow of -$29.2 million for fiscal 2024 (the year ended Dec 31, 2024), against -$67.4 million the year before. Source: the 10-K filed with the SEC on Mar 4, 2025. SEC
- What are NEVRO CORP's total assets?
- As of Dec 31, 2024, NEVRO CORP reported total assets of $553.8 million, against $635.7 million a year earlier (-12.9%). Source: the 10-K filed with the SEC on Mar 4, 2025. SEC
- What are NEVRO CORP's total liabilities?
- As of Dec 31, 2024, NEVRO CORP reported total liabilities of $322.8 million, against $342.6 million a year earlier (-5.8%). Source: the 10-K filed with the SEC on Mar 4, 2025. SEC
- What are NEVRO CORP's cash and cash equivalents?
- As of Dec 31, 2024, NEVRO CORP reported cash and cash equivalents of $94.5 million, against $104.2 million a year earlier (-9.3%). Source: the 10-K filed with the SEC on Mar 4, 2025. SEC
- What is NEVRO CORP's total debt?
- As of Dec 31, 2024, NEVRO CORP reported total debt of $225.6 million, against $211.5 million a year earlier (+6.7%). Source: the 10-K filed with the SEC on Mar 4, 2025. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1444380&period_type=annual&limit=5"Information only, not investment advice.